Multistep Differentiation Protocol for Insulin-Producing Beta-Cells
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The derivation and propagation of fully-differentiated insulin-producing beta-cells from human embryonic stem cells or induced pluripotent stem cells are challenging due to the lack of functional properties, mature phenotype, and inefficient production methods, as well as the absence of signals necessary for maturation and glucose response after transplantation.
Innovation Solution
A multistep differentiation protocol involving embryoid body formation, co-culturing with endothelial cells, and incubation with a bone morphogenic protein-related growth factor cocktail to differentiate pluripotent stem cells into insulin-producing beta-cells with functional properties and mature phenotype, achieving up to 95% conversion and maintaining functional phenotype in vivo.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of manufacture
If simple growth factor treatment is used to generate pancreatic endocrine precursors, then the differentiation process is simple, but the functional properties and maturation of insulin-producing cells are insufficient
Solution Approach 1:
The differentiation process is divided into multiple sequential stages: definitive endoderm formation, pancreatic progenitor development, and beta-cell maturation. Each stage uses specific growth factor combinations and durations, transforming a single complex process into manageable segments that collectively achieve full functional maturation.
Solution Approach 2:
The protocol applies preliminary actions by pre-differentiating cells into definitive endoderm before pancreatic progenitors, and further pre-differentiating into pancreatic progenitors before final beta-cell maturation. This staged preliminary action ensures proper developmental progression and functional competence.
2Reliability
If complex in vitro microenvironment with endothelial cell co-culturing is implemented, then the maturation and functional properties improve, but the device complexity and production difficulty increase
Solution Approach 1:
Endothelial cells serve as intermediary elements that provide crucial signals for beta-cell maturation. The co-culture system uses endothelial cells as mediators to transfer maturation signals from the extracellular matrix and growth factors to the pancreatic progenitors, enabling full functional development without direct manipulation of the progenitors themselves.
Solution Approach 2:
The culture system combines multiple cell types (pluripotent stem cells, endothelial cells) with extracellular matrix components and growth factors to create a composite microenvironment. This composite structure mimics the in vivo pancreatic niche, providing mechanical support, biochemical signals, and cellular interactions necessary for full maturation.
3Ease of manufacture
If traditional differentiation methods are used, then the production process is straightforward, but the efficiency of beta-cell generation is low
Solution Approach 1:
The protocol systematically changes multiple parameters including growth factor concentrations, culture medium composition, oxygen tension, and cell density at each differentiation stage. These parameter optimizations collectively increase beta-cell generation efficiency from traditional low levels to over 50% conversion of pluripotent stem cells.
Solution Approach 2:
The differentiation protocol maintains continuous exposure to appropriate growth factors and signaling molecules throughout each developmental stage, ensuring uninterrupted maturation signals. This continuous action prevents differentiation stalls and maximizes the efficiency of beta-cell generation from pluripotent stem cells.
Data Source
AI summary
Production of beta-cells from stem cells from pluripotent stem cells have always been significantly lacking in at least one of the following properties: 1) functional properties related to insulin-production and glucose signaling response, 2) mature phenotype such as biochemical markers or cell structures, 3) efficiency in production of differentiated cells. Described herein is multistep differentiation protocol which substantially overcomes all of the existing limitations. Pluripotent stem cells, including induced pluripotent stem cells (iPSCs), and embryonic stem cells (ESCs) can be differentiated using an embryoid body (EB) formation step, followed by B maturation via endothelial cells (EC) co-culturing and incubation with a sequential series of bone morphogenic protein (BMP)-related growth factor cocktails. The resulting cells displayed functional properties, including insulin-production and glucose signaling response, and mature phenotype of C-peptide expression.